Plain-English translation of NCT06660277 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether a newer type of dialysis filter called the Nipro Elisio HX dialyzer works better than the standard high-flux dialyzer currently used. The newer filter is designed to remove more waste products from your blood during kidney dialysis treatment. Researchers want to see if this improvement leads to better health outcomes and longer life for people with end-stage kidney disease.
Although the newer dialyzer has been available for over a decade and early studies suggest it may help, it hasn't been widely adopted because doctors need stronger proof that it actually makes a real difference in patients' lives. This large study will provide that proof.
You likely qualify if…
You likely don't qualify if…
You will continue receiving your regular dialysis treatments at your dialysis clinic—either with the newer filter or the standard filter, depending on which group you're randomly assigned to. The study will follow you for about 2.9 years on average, and researchers will track your health outcomes during this time. Beyond the type of filter used, your dialysis schedule and routine remain the same.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Canada